Optical control of cardiac electrophysiology by the photochromic ligand azobupivacaine 2
Authors:
Open Access
- 14 November 2024
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 182 (5) , 1125-1142
Abstract
Background and Purpose: Patients suffering from ischaemic heart disease and heart failure are at high risk of recurrent ventricular arrhythmias (VAs), eventually leading to sudden cardiac death. While high‐voltage shocks delivered by an implantable defibrillator may prevent sudden cardiac death, these interventions themselves impair quality of life and raise both morbidity and mortality, which accentuates the need for developing novel defibrillation techniques.Experimental Approach: Photopharmacology allows for reversible control of biological processes by light. When relying on synthetic and externally applied chromophores, it renders genetic modification of target cells dispensable and may hence be advantageous over optogenetic approaches. Here, the photochromic ligand azobupivacaine 2 (AB2) was probed as a modulator of cardiac electrophysiology in an ex vivo intact mouse heart model.Key Results: By reversibly blocking voltage‐gated Na+ and K+ channels, photoswitching of AB2 modulated both the ventricular effective refractory period and the conduction velocity in native heart tissue. Moreover, photoswitching of AB2 was able to convert VA into sinus rhythm.Conclusion and Implications: The present study provides the first proof of concept that AB2 enables gradual control of cardiac electrophysiology by light. AB2 may hence open the door to the development of an optical defibrillator based on photopharmacology.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (CRC1116 TPA01, SFB 1116, TP A01, GRK1873, SA 1785/7‐1, SA 1785/9‐1)
This publication has 83 references indexed in Scilit:
- Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythmsBasic Research in Cardiology, 2022
- The openCARP simulation environment for cardiac electrophysiologyComputer Methods and Programs in Biomedicine, 2021
- Sign Inversion in Photopharmacology: Incorporation of Cyclic Azobenzenes in Photoswitchable Potassium Channel Blockers and OpenersAngewandte Chemie, 2019
- Synthesis of Redshifted Azobenzene Photoswitches by Late‐Stage FunctionalizationChemistry – A European Journal, 2016
- Assessment of the effect of etomidate on voltage-gated sodium channels and action potentials in rat primary sensory cortex pyramidal neuronsEuropean Journal of Pharmacology, 2014
- Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunitiesCurrent Opinion in Pharmacology, 2014
- Optochemical GeneticsAngewandte Chemie International Edition, 2011
- Of circles and spirals: Bridging the gap between the leading circle and spiral wave concepts of cardiac reentryEP Europace, 2005
- Pharmacology of cardiac potassium channelsCardiovascular Research, 2004
- Therapeutic indices for transchest defibrillator shocks: Effective, damaging, and lethal electrical dosesAmerican Heart Journal, 1980